Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MarketWatch

J&J raises guidance for 2026 on strong start to the year

J&J raises guidance for 2026 on strong start to the year
ShareXFacebook

The healthcare giant saw sales of medications, which include Darzalex and Tremfya, increase 11% in the first three months of the year

M

Source

MarketWatch

Read full article at MarketWatch

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement